MedTrace Logo

Remote Home Assessment of Patients With Amyotrophic Lateral Sclerosis

NCT06046599 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2023-09-21

No results posted yet for this study

Summary

The goal of this observational study is the develop new ways of remotely monitoring the health and symptoms of people living with amyotrophic lateral sclerosis from within their homes. The main questions it aims to answer are:

* Can we integrate a new muscle monitoring device into Imperial College London's home monitoring platform?
* Can we investigate and understand the relationship between muscle activity and measure of patient behaviour (e.g., patient movement), physiology (e.g., pulse/blood pressure variation) and sleep quality from the home?
* Can we establish a home-based multimodal biomarker that tracks the neurodegenerative process in ALS? Participants will have passive internet-of-things sensors and internet-enabled medical devices installed in their homes for one year. Some sensors will record automatically without any interaction from the participants, but some will require participants to engage with daily (e.g., blood pressure monitor) on their own or with the help of a study partner.

Where possible, researchers will compare the collected data to other neurodegenerative diseases and healthy controls to understand differences over time.

Conditions

Sponsors & Collaborators

  • Imperial College London

    collaborator OTHER

  • King's College Hospital NHS Trust

    collaborator OTHER

  • King's College London

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-10-24
Primary Completion
2024-02-01
Completion
2024-02-01

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06046599 on ClinicalTrials.gov